Beximco Pharmaceuticals (LSE:BXP) Shares Outstanding (Basic Average): 446.1 Mil (As of Dec. 2024)


LSE:BXP Beximco Pharmaceuticals PLC LSE:BXP
97 GF Score
Price £0.43
View Full Analysis

What is Beximco Pharmaceuticals Shares Outstanding (Basic Average)?

Beximco Pharmaceuticals LSE:BXP 97 Shares Outstanding (Basic Average) is 446.1 Mil as of Dec. 2024. GuruFocus rates LSE:BXP with a GF Score™ of 97/100.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Beximco Pharmaceuticals's average basic shares outstanding for the quarter that ended in Dec. 2024 was 446.1 Mil.


Beximco Pharmaceuticals  (LSE:BXP) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Beximco Pharmaceuticals Shares Outstanding (Basic Average) Related Terms


Beximco Pharmaceuticals Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Shares Outstanding (Basic Average) Chart

Beximco Pharmaceuticals Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 446.11 446.11 446.11 446.11 446.11

Beximco Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 446.11 446.11 446.11 445.78 446.11
LSE:BXP
97GF Score
Beximco Pharmaceuticals PLC LSE:BXP
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beximco Pharmaceuticals Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 446.1 Mil mean?
Beximco Pharmaceuticals (LSE:BXP) has a Shares Outstanding (Basic Average) of 446.1 Mil as of Dec. 2024. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Shares Outstanding (Basic Average) too high?
Beximco Pharmaceuticals' current Shares Outstanding (Basic Average) is 446.1 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Shares Outstanding (Basic Average) compare to ZTS and UTHR?
Beximco Pharmaceuticals' Shares Outstanding (Basic Average) of 446.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Drug Manufacturers company?
A good Shares Outstanding (Basic Average) depends on the Drug Manufacturers industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Shares Outstanding (Basic Average) is 446.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (LSE:BXP) has a current Shares Outstanding (Basic Average) of 446.1 Mil. The current Shares Outstanding (Basic Average) is 446.1 Mil. Beximco Pharmaceuticals' overall GF Score™ is 97/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Beximco Pharmaceuticals (LSE:BXP), the current Shares Outstanding (Basic Average) is 446.1 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
97GF Score

Get the complete analysis for LSE:BXP

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.43
Price